NCT02082119View on ClinicalTrials.gov

Hypofractionated IMRT With Temozolomide for HGG

NACompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Glioma
Interventions
RADIATION

Hypofractionated IMRT

Hypofractionated IMRT

Trial Locations (1)

20100

Istituto Clinico Humanitas, Milan

All Listed Sponsors
lead

Istituto Clinico Humanitas

OTHER

NCT02082119 - Hypofractionated IMRT With Temozolomide for HGG | Biotech Hunter | Biotech Hunter